Molecular basis for prostaglandin production in hosts and parasites

Trends in Parasitology

Volumn 23, Issue 7, 2007, Pages 325-331

  Kubata, Bruno Kilunga ^a   Duszenko, Michael ^b   Martin, K Samuel ^c   Urade, Yoshihiro ^d  

^a Biosciences Eastern and Central Africa (a NEPAD centre of excellence)   (Kenya)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c U S ARMY   (United States)

^d OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; PHOSPHOLIPASE A2; PROSTAGLANDIN; PROSTAGLANDIN A2; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

ACANTHAMOEBA; AMOEBA PROTEUS; ASCARIS; ASTROCYTE; AUTOCRINE EFFECT; CRITHIDIA FASCICULATA; DISEASE COURSE; ENTAMOEBA HISTOLYTICA; ENZYME ACTIVITY; ENZYMOLOGY; HOST CELL; HOST PARASITE INTERACTION; HUMAN; INFECTION; LEISHMANIA; MACROPHAGE; MALARIA; METAZOON; MOLECULAR BIOLOGY; NEMATODE; NERVE FIBER GROWTH; NONHUMAN; ONCHOCERCA VOLVULUS; OSMOREGULATION; PHAGOCYTOSIS; PLASMODIUM FALCIPARUM; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTOZOON; REVIEW; SCHISTOSOMA; TACHYZOITE; TOXOPLASMA GONDII; TREMATODE; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI;

ANIMALS; ARACHIDONIC ACID; HELMINTHIASIS; HELMINTHS; HUMANS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; PROTOZOA; PROTOZOAN INFECTIONS;

ANIMALIA;

EID: 34250651718     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2007.05.005     Document Type: Review

References (60)

1. 2 system. J. Appl. Physiol. 92 (2002) 863-868
2. Miller S.B. Prostaglandins in health and disease: an overview. Semin. Arthritis Rheum. 36 (2006) 37-49
3. Rowley A.F., et al. Prostaglandins in non-insectan invertebrates: recent insights and unsolved problems. J. Exp. Biol. 208 (2005) 3-14
4. Weems C.W., et al. Prostaglandins and reproduction in female farm animals. Vet. J. 171 (2006) 206-228
5. Noverr M.C., et al. Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin. Microbiol. Rev. 16 (2003) 517-533
6. Daugschies A., and Joachim A. Eicosanoids in parasites and parasitic infections. Adv. Parasitol. 46 (2000) 181-240
7. Kilunga Kubata B., et al. Plasmodium falciparum produces prostaglandins that are pyrogenic, somnogenic, and immunosuppressive substances in humans. J. Exp. Med. 188 (1998) 1197-1202
8. 2α in the parasitic protozoan Trypanosoma brucei. Int. Congr. Ser. 1233 (2002) 461-466
9. 2α synthase in Trypanosoma brucei. J. Exp. Med. 192 (2000) 1327-1337
10. Kubata B.K., et al. A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. J. Exp. Med. 196 (2002) 1241-1251
11. 2 reductase in Leishmania. Int. J. Parasitol. 33 (2003) 221-228
12. 2α synthase. J. Biochem. (Tokyo) 132 (2002) 859-861
13. Hadas E., and Mazur T. Biosynthesis of prostaglandins in pathogenic and nonpathogenic strains of Acanthamoeba spp. Parasitol. Res. 83 (1997) 296-299
14. 2α. Prostaglandins Leukot. Med. 22 (1986) 259-264
15. Belley A., and Chadee K. Eicosanoid production by parasites: from pathogenesis to immunomodulation?. Parasitol. Today 11 (1995) 327-334
16. 2 on amoebic liver abscess formation in hamsters. Prostaglandins 53 (1997) 411-421
17. Denis M., and Chadee K. In vitro and in vivo studies of macrophage functions in amebiasis. Infect. Immun. 56 (1988) 3126-3131
18. Sanchez-Ramirez B., et al. Entamoeba histolytica: induction of cyclooxygenase-2 expression during amoebic liver abscess formation in hamsters (Mesocricetus auratus). Exp. Parasitol. 106 (2004) 119-125
19. Dey I., et al. Identification and characterization of a cyclooxygenase-like enzyme from Entamoeba histolytica. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13561-13566
20. Prusch R.D., et al. Prostaglandins may play a signal-coupling role during phagocytosis in Amoeba proteus. Cell Tissue Res. 255 (1989) 553-557
21. Wanke C., et al. Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnostic and response to therapy. Am. J. Trop. Med. Hyg. 36 (1987) 509-516
22. Luft B.J., et al. Primary and reactivated Toxoplasma infection in patients with cardiac transplants: clinical spectrum and problems in diagnosis in a defined population. Ann. Intern. Med. 99 (1983) 27-31
23. Rozenfeld C., et al. Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration. Infect. Immun. 71 (2003) 2047-2057
24. 2 induces programmed cell death in Trypanosoma brucei bloodstream forms. Cell Death Differ. 12 (2005) 335-346
25. Figarella K., et al. Prostaglandin-induced programmed cell death in Trypanosoma brucei involves oxidative stress. Cell Death Differ. 13 (2006) 1802-1814
26. Pinge-Filho P., et al. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell. Immunol. 193 (1999) 90-98
27. Michelin M.A., et al. Inducible cyclooxygenase-released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection. Exp. Parasitol. 111 (2005) 71-79
28. Reiner N.E. Host-parasite relationship in murine leishmaniasis donovani: dynamics of pathophysiologic and immunologic changes. Infect. Immun. 38 (1982) 1223-1230
29. Gutierrez Y., et al. Pathological changes in murine leishmaniasis (Leishmania donovani) with specific reference to the dynamics of granuloma formation in liver. Am. J. Pathol. 114 (1984) 222-230
30. 2 synthesis. Parasite Immunol. 23 (2001) 177-184
31. 2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J. Exp. Med. 193 (2001) 1135-1147
32. 2 in interleukin-10-mediated host immunoregulation by skin stage schistosomula of Schistosoma mansoni. J. Immunol. 165 (2000) 4567-4574
33. Salafsky B., and Fusco A. Schistosoma mansoni: a comparison of secreted vs non-secreted eicosanoids in developing schistosomula and adults. Exp. Parasitol. 64 (1987) 361-367
34. Nevhutalu P.A., et al. Schistosoma mansoni and Trichobilharzia ocellata: comparison of secreted cercarial eicosanoids. J. Parasitol. 79 (1993) 130-133
35. 2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion. Eur. J. Immunol. 33 (2003) 2764-2772
36. Meyer D.J., et al. Purification and characterization of prostaglandin-H-E-isomerase, a sigma-class glutathione S-transferase, from Ascaridia galli. Biochem. J. 313 (1996) 223-227
37. Sommer A., et al. Structural analysis and antibody response to the extracellular glutathione S-transferase from Onchocerca volvulus. Infect. Immun. 69 (2001) 7718-7728
38. 2. Infect. Immun. 71 (2003) 3603-3606
39. + T cells. J. Immunol. 175 (2005) 1483-1490
40. Braun D., et al. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 106 (2005) 2375-2381
41. + T regulatory cell activities in lung cancer. Cancer Res. 65 (2005) 5211-5220
42. Chu F.L., et al. Arachidonic acid synthetic pathways of the oyster protozoan parasite, Perkinsus marinus: evidence for usage of a delta-8 pathway. Mol. Biochem. Parasitol. 133 (2004) 45-51
43. Frayha G.J., and Smyth J.D. Lipid metabolism in parasitic helminths. Adv. Parasitol. 22 (1983) 309-387
44. Patnaik P.K., et al. Molecular species analysis of phospholipids from Trypanosoma brucei bloodstream and procyclic forms. Mol. Biochem. Parasitol. 58 (1993) 97-106
45. Saffer L.D., and Schwartzman J.D. A soluble phospholipase of Toxoplasma gondii associated with host cell penetration. J. Protozool. 38 (1991) 454-460
46. 2 by chloroquine, quinine, and arteether. J. Parasitol. 79 (1993) 565-570
47. Ridgley E.L., and Ruben L. Phospholipase from Trypanosoma brucei releases arachidonic acid by sequential sn-1, sn-2 deacylation of phospholipids. Mol. Biochem. Parasitol. 114 (2001) 29-40
48. 2 from Trypanosoma brucei gambiense and Trypanosoma brucei brucei: inhibition by organotins. J. Enzyme Inhib. 16 (2001) 433-441
49. 2 from Trypanosoma congolense: characterization and haematological properties. Cell Biochem. Funct. 11 (1993) 125-130
50. 2-sensitive components of the parasite membrane. Biochem. Biophys. Res. Commun. 121 (1984) 931-939
51. 2 phospholipase. Infect. Immun. 59 (1991) 1442-1447
52. Johnson K.A., et al. Crystal structure of the 28 kDa glutathione S-transferase from Schistosoma haematobium. Biochemistry 42 (2003) 10084-10094
53. 2 reductase provides insight into the catalytic mechanism of aldo-ketoreductases. J. Biol. Chem. 280 (2005) 26371-26382
54. Jez J.M., and Penning T.M. The aldo-keto reductase (AKR) superfamily: an update. Chem. Biol. Interact. 130-132 (2001) 499-525
55. Suzuki T., et al. cDNA cloning, expression, and mutagenesis study of liver-type prostaglandin F synthase. J. Biol. Chem. 274 (1999) 241-248
56. Komoto J., et al. Crystal structure of human prostaglandin F synthase (AKR1C3). Biochemistry 43 (2004) 2188-2198
57. Uchiyama N., et al. Antichagasic activity of komaroviquinone is due to generation of reactive oxygen species catalyzed by Trypanosoma cruzi Old Yellow Enzyme. Antimicrob. Agents Chemother. 49 (2005) 5123-5126
58. Handman E., et al. The Leishmania promastigote surface antigen 2 complex is differentially expressed during parasite life cycle. Mol. Biochem. Parasitol. 74 (1995) 189-200
59. Samaras N., and Spithill T.W. The developmentally-regulated P100/11E gene of Leishmania major shows homology to a superfamily of reductase genes. J. Biol. Chem. 264 (1989) 4251-4254
60. Sacks D., and Kamhawi S. Molecular aspects of parasite-vector and vector-host interactions in leishmaniasis. Annu. Rev. Microbiol. 55 (2001) 453-483